Replies to post #438 on Aptose Biosciences Inc (APTO)

[dcaf7]

Lack of activity as monotherapy revealed yesterday is not encouraging and lowers my expectations for combo. What are they going to use as control arm? Ven is not good because many patients are R/R to Ven. Tusp is not good because it doesn't work.